Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Skull Fractures | 2 | 2021 | 53 | 1.04 | Why? |
Maxillofacial Injuries | 1 | 2021 | 81 | 0.80 | Why? |
Ageusia | 6 | 2020 | 918 | 0.71 | Why? |
Olfaction Disorders | 11 | 2021 | 3704 | 0.63 | Why? |
Surgical Oncology | 1 | 2021 | 923 | 0.49 | Why? |
Head and Neck Neoplasms | 2 | 2021 | 1568 | 0.43 | Why? |
Sensory Thresholds | 2 | 2020 | 115 | 0.38 | Why? |
Taste Disorders | 4 | 2020 | 1720 | 0.36 | Why? |
Reconstructive Surgical Procedures | 4 | 2019 | 860 | 0.36 | Why? |
Computer-Aided Design | 2 | 2019 | 94 | 0.22 | Why? |
Free Tissue Flaps | 2 | 2018 | 86 | 0.21 | Why? |
Carcinoma, Squamous Cell | 2 | 2018 | 902 | 0.19 | Why? |
Mandibular Reconstruction | 1 | 2018 | 14 | 0.19 | Why? |
Ethmoid Sinus | 1 | 2018 | 10 | 0.19 | Why? |
Neuritis | 1 | 2020 | 109 | 0.19 | Why? |
Adenolymphoma | 1 | 2017 | 1 | 0.19 | Why? |
Maxillary Sinus Neoplasms | 1 | 2018 | 9 | 0.19 | Why? |
Miller Fisher Syndrome | 1 | 2020 | 101 | 0.18 | Why? |
Lip Neoplasms | 1 | 2017 | 8 | 0.18 | Why? |
Salivary Glands, Minor | 1 | 2017 | 16 | 0.18 | Why? |
Ear, External | 1 | 2018 | 19 | 0.18 | Why? |
Tongue Neoplasms | 1 | 2018 | 54 | 0.18 | Why? |
Salivary Gland Neoplasms | 1 | 2017 | 25 | 0.18 | Why? |
Arthrocentesis | 1 | 2017 | 13 | 0.18 | Why? |
Facial Bones | 1 | 2017 | 12 | 0.18 | Why? |
Nose Neoplasms | 1 | 2018 | 43 | 0.18 | Why? |
Temporomandibular Joint | 1 | 2017 | 24 | 0.18 | Why? |
Carcinoma in Situ | 1 | 2018 | 58 | 0.17 | Why? |
Epistaxis | 1 | 2018 | 96 | 0.16 | Why? |
Natural Orifice Endoscopic Surgery | 1 | 2018 | 127 | 0.16 | Why? |
Paranasal Sinus Neoplasms | 1 | 2016 | 55 | 0.16 | Why? |
Temporomandibular Joint Disorders | 1 | 2017 | 77 | 0.15 | Why? |
Otolaryngologists | 1 | 2021 | 533 | 0.15 | Why? |
Surgery, Computer-Assisted | 1 | 2018 | 183 | 0.15 | Why? |
Surgical Wound Infection | 2 | 2018 | 501 | 0.15 | Why? |
Facial Injuries | 1 | 2017 | 173 | 0.14 | Why? |
Paranasal Sinuses | 1 | 2017 | 217 | 0.14 | Why? |
Papillomaviridae | 1 | 2018 | 404 | 0.13 | Why? |
Mouth Neoplasms | 1 | 2018 | 463 | 0.11 | Why? |
Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
Biomarkers, Tumor | 2 | 2018 | 1314 | 0.11 | Why? |
Sinusitis | 1 | 2017 | 649 | 0.10 | Why? |
Papillomavirus Infections | 1 | 2018 | 861 | 0.10 | Why? |
Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.09 | Why? |
Self Report | 1 | 2020 | 3802 | 0.09 | Why? |
Lymphocytes | 1 | 2018 | 3056 | 0.07 | Why? |
Neutrophils | 2 | 2018 | 5476 | 0.07 | Why? |
Pneumonia, Viral | 10 | 2020 | 243684 | 0.07 | Why? |
Coronavirus Infections | 10 | 2020 | 253789 | 0.06 | Why? |
Cause of Death | 1 | 2016 | 4823 | 0.06 | Why? |
Betacoronavirus | 10 | 2020 | 204454 | 0.06 | Why? |
Pandemics | 13 | 2021 | 389249 | 0.06 | Why? |
Middle Aged | 14 | 2021 | 270681 | 0.06 | Why? |
Humans | 25 | 2021 | 930598 | 0.05 | Why? |
Coronavirus | 2 | 2020 | 18339 | 0.05 | Why? |
Neoplasm Staging | 2 | 2018 | 1999 | 0.05 | Why? |
Surgical Mesh | 1 | 2019 | 55 | 0.05 | Why? |
Orbit | 1 | 2019 | 51 | 0.05 | Why? |
Fibula | 1 | 2018 | 9 | 0.05 | Why? |
Papillomavirus E7 Proteins | 1 | 2018 | 20 | 0.05 | Why? |
Prostheses and Implants | 1 | 2019 | 116 | 0.05 | Why? |
Ophthalmic Artery | 1 | 2018 | 16 | 0.05 | Why? |
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 45 | 0.05 | Why? |
Sphenoid Sinus | 1 | 2018 | 26 | 0.05 | Why? |
Sleep Bruxism | 1 | 2017 | 10 | 0.05 | Why? |
Surgical Wound Dehiscence | 1 | 2018 | 18 | 0.05 | Why? |
Ligation | 1 | 2018 | 84 | 0.04 | Why? |
Viscosupplements | 1 | 2017 | 17 | 0.04 | Why? |
Maxillary Sinus | 1 | 2018 | 51 | 0.04 | Why? |
Neck Dissection | 1 | 2018 | 109 | 0.04 | Why? |
Titanium | 1 | 2019 | 175 | 0.04 | Why? |
Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
Injections | 1 | 2017 | 237 | 0.04 | Why? |
Blood Loss, Surgical | 1 | 2018 | 211 | 0.04 | Why? |
Hyaluronic Acid | 1 | 2017 | 168 | 0.04 | Why? |
Operative Time | 1 | 2018 | 450 | 0.04 | Why? |
Lymphatic Metastasis | 1 | 2018 | 537 | 0.04 | Why? |
Male | 14 | 2020 | 367725 | 0.04 | Why? |
Follow-Up Studies | 3 | 2018 | 17020 | 0.04 | Why? |
Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.04 | Why? |
Mouth Mucosa | 1 | 2017 | 323 | 0.03 | Why? |
Neoplasm Invasiveness | 1 | 2016 | 582 | 0.03 | Why? |
Hematoma | 1 | 2018 | 305 | 0.03 | Why? |
Edema | 1 | 2017 | 333 | 0.03 | Why? |
Adult | 10 | 2020 | 244371 | 0.03 | Why? |
Predictive Value of Tests | 2 | 2020 | 9537 | 0.03 | Why? |
Female | 12 | 2020 | 380317 | 0.03 | Why? |
Printing, Three-Dimensional | 1 | 2019 | 624 | 0.03 | Why? |
Incidental Findings | 1 | 2017 | 487 | 0.03 | Why? |
Pseudomonas Infections | 1 | 2018 | 425 | 0.03 | Why? |
Klebsiella Infections | 1 | 2018 | 466 | 0.03 | Why? |
False Positive Reactions | 1 | 2018 | 1338 | 0.03 | Why? |
Nasal Cavity | 1 | 2018 | 909 | 0.03 | Why? |
Transcription, Genetic | 1 | 2018 | 1326 | 0.03 | Why? |
Smell | 1 | 2021 | 1851 | 0.03 | Why? |
Disease-Free Survival | 1 | 2016 | 1654 | 0.03 | Why? |
Italy | 3 | 2020 | 38444 | 0.03 | Why? |
Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.03 | Why? |
Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
Platelet Count | 1 | 2016 | 1381 | 0.03 | Why? |
Aged | 7 | 2020 | 215776 | 0.02 | Why? |
Postoperative Complications | 2 | 2018 | 5861 | 0.02 | Why? |
Staphylococcal Infections | 1 | 2018 | 1099 | 0.02 | Why? |
Severity of Illness Index | 3 | 2020 | 48226 | 0.02 | Why? |
DNA, Viral | 1 | 2018 | 2521 | 0.02 | Why? |
Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
Kaplan-Meier Estimate | 1 | 2016 | 4260 | 0.02 | Why? |
Preoperative Care | 1 | 2016 | 1515 | 0.02 | Why? |
Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
Endoscopy | 1 | 2017 | 1564 | 0.02 | Why? |
Software | 1 | 2018 | 2501 | 0.02 | Why? |
Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
Lymphocyte Count | 1 | 2016 | 4758 | 0.02 | Why? |
Proportional Hazards Models | 1 | 2016 | 6543 | 0.02 | Why? |
RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
Survival Analysis | 1 | 2016 | 7592 | 0.02 | Why? |
Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
China | 1 | 2020 | 50654 | 0.01 | Why? |
Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
Risk Assessment | 1 | 2016 | 25439 | 0.01 | Why? |
Lung | 1 | 2021 | 31049 | 0.01 | Why? |
Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
Salzano's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_